Research Project

Project Title:	Phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	This is a phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients.
Lead principal investigator(s):	Gaetano La Manna, Bologna
Co-investigator(s):	Olga Baraldi, Bologna
Project Period:	11/2021 - 11/2050
Sponsors:	Industry